Correction: Encapsulation of the dual FLAP/mPEGS‑1 inhibitor BRP‑187 into acetalated dextran and PLGA nanoparticles improves its cellular bioactivity.
作者信息
Shkodra Blerina, Kretzer Christian, Jordan Paul M, Klemm Paul, Koeberle Andreas, Pretzel David, Banoglu Erden, Lorkowski Stefan, Wallert Maria, Höppener Stephanie, Stumpf Steffi, Vollrath Antje, Schubert Stephanie, Werz Oliver, Schubert Ulrich S
机构信息
Laboratory of Organic and Macromolecular Chemistry (IOMC), Friedrich Schiller University Jena, Humboldtstraße 10, 07743, Jena, Germany.
Department of Pharmaceutical/Medicinal Chemistry, Institute of Pharmacy, Friedrich Schiller University Jena, Philosophenweg 14, 07743, Jena, Germany.
出版信息
J Nanobiotechnology. 2024 Feb 27;22(1):77. doi: 10.1186/s12951-024-02341-7.
Abstract
摘要
相似文献
1
Correction: Encapsulation of the dual FLAP/mPEGS‑1 inhibitor BRP‑187 into acetalated dextran and PLGA nanoparticles improves its cellular bioactivity.更正：将双FLAP/mPEGS-1抑制剂BRP-187封装到缩醛化葡聚糖和聚乳酸-羟基乙酸共聚物纳米颗粒中可提高其细胞生物活性。
J Nanobiotechnology. 2024 Feb 27;22(1):77. doi: 10.1186/s12951-024-02341-7.
2
Encapsulation of the dual FLAP/mPEGS-1 inhibitor BRP-187 into acetalated dextran and PLGA nanoparticles improves its cellular bioactivity.将双重 FLAP/mPEGS-1 抑制剂 BRP-187 包封入缩醛化葡聚糖和 PLGA 纳米粒中可提高其细胞生物活性。
J Nanobiotechnology. 2020 May 14;18(1):73. doi: 10.1186/s12951-020-00620-7.
3
Ethoxy acetalated dextran-based nanocarriers accomplish efficient inhibition of leukotriene formation by a novel FLAP antagonist in human leukocytes and blood.乙氧基乙酰化葡聚糖基纳米载体通过新型 FLAP 拮抗剂在人白细胞和血液中有效抑制白三烯的形成。
Cell Mol Life Sci. 2021 Dec 31;79(1):40. doi: 10.1007/s00018-021-04039-7.
4
Ethoxy acetalated dextran nanoparticles for drug delivery: A comparative study of formulation methods.用于药物递送的乙氧基缩醛化葡聚糖纳米颗粒：制剂方法的比较研究
Int J Pharm X. 2023 Feb 24;5:100173. doi: 10.1016/j.ijpx.2023.100173. eCollection 2023 Dec.
5
Encapsulation of the Anti-inflammatory Dual FLAP/sEH Inhibitor Diflapolin Improves the Efficiency in Human Whole Blood.抗炎双重 FLAP/sEH 抑制剂地氟波生包封提高了人全血的效率。
J Pharm Sci. 2022 Jun;111(6):1843-1850. doi: 10.1016/j.xphs.2021.10.030. Epub 2021 Oct 29.
6
Improved Bioactivity of the Natural Product 5-Lipoxygenase Inhibitor Hyperforin by Encapsulation into Polymeric Nanoparticles.天然产物 5-脂氧合酶抑制剂贯叶连翘素通过包封到聚合物纳米粒中提高其生物活性。
Mol Pharm. 2020 Mar 2;17(3):810-816. doi: 10.1021/acs.molpharmaceut.9b01051. Epub 2020 Feb 7.
7
Novel insights into appropriate encapsulation methods for bioactive compounds into polymers: a study with peptides and HDAC inhibitors.生物活性化合物包封于聚合物中的适宜包封方法的新见解：肽和组蛋白去乙酰化酶抑制剂的研究
Macromol Biosci. 2014 Jan;14(1):69-80. doi: 10.1002/mabi.201300213. Epub 2013 Aug 21.
8
Promoting early neovascularization of SIS-repaired abdominal wall by controlled release of bioactive VEGF.通过生物活性血管内皮生长因子的控释促进小肠黏膜下层修复腹壁的早期血管新生
RSC Adv. 2018 Jan 25;8(9):4548-4560. doi: 10.1039/c7ra11954b. eCollection 2018 Jan 24.
9
Encapsulation of low lipophilic and slightly water-soluble dihydroartemisinin in PLGA nanoparticles with phospholipid to enhance encapsulation efficiency and in vitro bioactivity.用磷脂将低亲脂性且微溶于水的双氢青蒿素包裹于聚乳酸-羟基乙酸共聚物纳米粒中，以提高包封率和体外生物活性。
J Microencapsul. 2016 Feb;33(1):43-52. doi: 10.3109/02652048.2015.1114042. Epub 2015 Dec 1.
10
Resveratrol-loaded PLGA nanoparticles: enhanced stability, solubility and bioactivity of resveratrol for non-alcoholic fatty liver disease therapy.负载白藜芦醇的聚乳酸-羟基乙酸共聚物纳米粒：增强白藜芦醇的稳定性、溶解性及生物活性用于非酒精性脂肪性肝病治疗
R Soc Open Sci. 2018 Nov 14;5(11):181457. doi: 10.1098/rsos.181457. eCollection 2018 Nov.
本文引用的文献
1
Encapsulation of the dual FLAP/mPEGS-1 inhibitor BRP-187 into acetalated dextran and PLGA nanoparticles improves its cellular bioactivity.将双重 FLAP/mPEGS-1 抑制剂 BRP-187 包封入缩醛化葡聚糖和 PLGA 纳米粒中可提高其细胞生物活性。
J Nanobiotechnology. 2020 May 14;18(1):73. doi: 10.1186/s12951-020-00620-7.
Zotero 插件